Previous close | 2,713.56 |
Open | 0.00 |
Bid | 2,650.01 x 100 |
Ask | 2,777.59 x 2500 |
Day's range | 2,713.56 - 2,713.56 |
52-week range | 2,250.80 - 3,070.53 |
Volume | |
Avg. volume | 568 |
Market cap | 4.792T |
Beta (5Y monthly) | 0.59 |
PE ratio (TTM) | 47.85 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 103.69 (3.82%) |
Ex-dividend date | 12 Apr 2024 |
1y target est | N/A |
Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.
In this article, we discuss 15 best S&P 500 dividend stocks to buy now. You can skip our detailed analysis of dividend stocks in the S&P 500 and their past performance, and go directly to read 5 Best S&P 500 Dividend Stocks To Buy Now. It’s been a dynamic first quarter for the stock market. […]